The terms of the tentative approval mean the drug – categorised as a biosimilar in Europe but not in the US – is subject to an automatic stay of up to 30 months. Basaglar is indicated to ...

Basaglar is a brand-name drug, and no generic form of this medication exists. Keep reading to learn more about how Medicare covers insulin, insulin pumps, and other insulin-related supplies.

Some Medicare plans may cover Basaglar, but it varies by plan. Learn which plans cover Basaglar, how to find coverage, and what you can expect to pay.